Enabled by WuXi Biologics’ industry-leading integrated technology platform, velaglucerase-beta for injection has successfully advanced from concept to commercialization.Velaglucerase-beta for injection, as the first and the only locally developed enzyme replacement therapy (ERT) for Gaucher disease in China, marks a significant…
SIEW 2025 Registration Opens: Envisioning Energy Tomorrow, Building Systems Today
SINGAPORE, July 31, 2025 /PRNewswire/ — Registration is now open for the 18th Singapore International Energy Week (SIEW), happening from 27 to 31 October in Singapore. Organised by the Energy Market Authority (EMA), SIEW 2025 will explore the theme “Envisioning…